Combining Dapagliflozin and Eplerenone Further Reduces Albuminuria in CKD
Study findings suggest the nephroprotective effects of both drug classes are complementary.
Proteinuria
Hypertension Care May Be Improved by Disclosing APOL1 Genetic Test Results
Nearly all studied patients had favorable reactions to APOL1 genetic testing and receiving results.
Improving Cardiovascular Health May Reduce Proteinuria Risk
Investigators studied the effect of adhering to 7 cardiovascular health metrics on development of proteinuria.
Purified Cortrophin Gel Now Available for Certain Chronic Autoimmune Disorders
The product is available through a network of specialty pharmacies and distributors.
Tarpeyo Now Available to Reduce Proteinuria in Primary IgA Nephropathy
To help patients gain access to treatment, Calliditas Therapeutics has launched a patient support program called Tarpeyo Touchpoints.
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
Belimumab Shows Efficacy in Real-World Lupus Nephritis Population
Renal response at 6 months strongly predicted belimumab’s durability.
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
Combination of eGFR and UACR Better Predicts CKD Progression
Using changes in UACR and eGFR as an alternative outcome for kidney failure in trials of CKD progression warrants further evaluation, according to investigators.
Primary Nephrotic Syndrome Increases ESKD, Cardiovascular Risks
Among the study findings, primary nephrotic syndrome was associated with an excess risk of heart failure hospitalization.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...